$OPK For anyone wondering about yesterday’s drop, I haven’t found any new negative company or ModeX news that explains it. The convertible-note conversion window could be creating some dilution/selling concern, but that’s only a possibility. Meanwhile, Zacks itself confirmed Monday that OPK is now a Zacks Rank
#1 (Strong Buy). No new negative MDX2001, Merck EBV, BARDA or other ModeX development that I can find. For now, yesterday looks more like market/share-structure pressure than a change in the underlying story.